AMN vs. CHE, RCM, CRVL, AMED, MD, CCRN, LH, DGX, DVA, and RHI
Should you be buying AMN Healthcare Services stock or one of its competitors? The main competitors of AMN Healthcare Services include Chemed (CHE), R1 RCM (RCM), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), Cross Country Healthcare (CCRN), Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), and Robert Half (RHI).
Chemed (NYSE:CHE) and AMN Healthcare Services (NYSE:AMN) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, community ranking, analyst recommendations, dividends, media sentiment and earnings.
Chemed currently has a consensus target price of $673.50, suggesting a potential upside of 23.88%. AMN Healthcare Services has a consensus target price of $75.57, suggesting a potential upside of 36.81%. Given Chemed's higher probable upside, analysts clearly believe AMN Healthcare Services is more favorable than Chemed.
Chemed has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.
Chemed has a beta of 0.46, indicating that its stock price is 54% less volatile than the S&P 500. Comparatively, AMN Healthcare Services has a beta of 0.22, indicating that its stock price is 78% less volatile than the S&P 500.
Chemed has a net margin of 12.36% compared to Chemed's net margin of 4.13%. Chemed's return on equity of 31.39% beat AMN Healthcare Services' return on equity.
In the previous week, Chemed had 1 more articles in the media than AMN Healthcare Services. MarketBeat recorded 6 mentions for Chemed and 5 mentions for AMN Healthcare Services. Chemed's average media sentiment score of 1.02 beat AMN Healthcare Services' score of 0.50 indicating that AMN Healthcare Services is being referred to more favorably in the news media.
AMN Healthcare Services received 108 more outperform votes than Chemed when rated by MarketBeat users. Likewise, 68.87% of users gave AMN Healthcare Services an outperform vote while only 63.46% of users gave Chemed an outperform vote.
95.9% of Chemed shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 3.3% of Chemed shares are owned by insiders. Comparatively, 0.9% of AMN Healthcare Services shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Summary
Chemed beats AMN Healthcare Services on 10 of the 18 factors compared between the two stocks.
Get AMN Healthcare Services News Delivered to You Automatically
Sign up to receive the latest news and ratings for AMN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AMN Healthcare Services Competitors List
Related Companies and Tools
